Published in Zentralbl Allg Pathol on January 01, 1989
Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart (2001) 7.87
Relationship between medication errors and adverse drug events. J Gen Intern Med (1995) 7.81
Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. Science (1989) 7.15
Public-health impact of outdoor and traffic-related air pollution: a European assessment. Lancet (2000) 6.95
A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science (1995) 5.46
A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med (1994) 5.03
Evolution of organic aerosols in the atmosphere. Science (2009) 4.82
Isolated noncompaction of the myocardium in adults. Mayo Clin Proc (1997) 4.63
Presurgical evaluation of epilepsy. Brain (2001) 4.47
Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells. EMBO J (1987) 3.81
Outbreake of Marburg virus disease in Johannesburg. Br Med J (1975) 3.51
Absence of N-acetylaspartate in the human brain: impact on neurospectroscopy? Ann Neurol (2001) 3.36
Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol (1987) 3.22
Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution. Science (1989) 2.74
Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus. J Gen Virol (1986) 2.65
Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120. J Biol Chem (1988) 2.48
ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery. Epilepsia (2001) 2.42
Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur J Immunol (1994) 2.19
Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules. Nature (1989) 2.17
Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol (2006) 2.02
Do case studies mislead about the nature of reality? J Med Ethics (1999) 1.99
Relation between calcium intake and fat oxidation in adult humans. Int J Obes Relat Metab Disord (2003) 1.98
Size matters more than chemistry for cloud-nucleating ability of aerosol particles. Science (2006) 1.96
Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV). Virology (1994) 1.94
Nucleotides that determine Escherichia coli tRNA(Arg) and tRNA(Lys) acceptor identities revealed by analyses of mutant opal and amber suppressor tRNAs. Proc Natl Acad Sci U S A (1990) 1.92
Rainforest aerosols as biogenic nuclei of clouds and precipitation in the Amazon. Science (2010) 1.86
Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? J Infect Dis (2001) 1.79
Functional evidence for indirect recognition of G.U in tRNA(Ala) by alanyl-tRNA synthetase. Science (1996) 1.78
Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime. Vaccine (1998) 1.74
Frequency and long-term impact of myonecrosis after coronary stenting. Eur Heart J (2002) 1.69
Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Arzneimittelforschung (1988) 1.67
Closed-chest coronary artery surgery on the beating heart with the use of a robotic system. J Thorac Cardiovasc Surg (2000) 1.67
[True aneurysm of the ascending aorta in HIV disease]. Schweiz Med Wochenschr (1994) 1.63
Ion channel modulation by NS 1619, the putative BKCa channel opener, in vascular smooth muscle. Br J Pharmacol (1994) 1.60
Association of transfer RNA acceptor identity with a helical irregularity. Science (1988) 1.56
Dystonic posturing in complex partial seizures of temporal lobe onset: a new lateralizing sign. Neurology (1989) 1.55
Role of magnesium sulfate in postoperative analgesia. Anesthesiology (1996) 1.53
Postoperative neurological deficits may occur despite unchanged intraoperative somatosensory evoked potentials. Ann Neurol (1986) 1.53
Embolization of biologic glue during repair of aortic dissection. Ann Thorac Surg (1995) 1.52
Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma. J Immunol (1997) 1.52
Automatisms with preserved responsiveness: a lateralizing sign in psychomotor seizures. Neurology (1995) 1.52
Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc Natl Acad Sci U S A (1982) 1.48
Structure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor. Biochemistry (1991) 1.48
Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation (1989) 1.47
Fibromuscular hyperplasia: extension of the disease and therapeutic outcome. Results of the University Hospital Zurich Cooperative Study on Fibromuscular Hyperplasia. Nephron (1986) 1.47
The species concept and its application to tailed phages. Arch Virol (1992) 1.45
Reduced antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus. Clin Exp Immunol (1975) 1.44
Diffuse microvascular pulmonary thrombosis associated with primary antiphospholipid antibody syndrome. Eur Respir J (1997) 1.44
[Do advers health effects of chrysotile and amphibole asbestos differ?]. Pneumologie (2012) 1.43
Immunoprevention of Friend virus-induced erythroleukemia by vaccination with viral envelope glycoprotein complexes. Virology (1981) 1.43
A dose-determining trial of heparinase-I (Neutralase) for heparin neutralization in coronary artery surgery. Anesth Analg (2001) 1.42
Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing postoperative bleeding and use of donated blood. J Thorac Cardiovasc Surg (1994) 1.42
Atomic-scale visualization of inertial dynamics. Science (2005) 1.42
Unsedated esophagoscopy for the diagnosis of esophageal varices in patients with cirrhosis. Endoscopy (2000) 1.41
DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice. Vaccine (1998) 1.40
[Absence of correlation between the concentrations of carcinoembryonic antigen (CEA) and the tumor growth factor beta 2 (TGFB2) in the two main types of breast macrocysts]. Rev Esp Med Nucl (1999) 1.40
Variants in clones of gene-machine-synthesized oligodeoxynucleotides. Nucleic Acids Res (1986) 1.40
New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestation. Klin Wochenschr (1979) 1.39
Persisting myocardial sinusoids of both ventricles as an isolated anomaly: echocardiographic, angiographic, and pathologic anatomical findings. Cardiovasc Intervent Radiol (1986) 1.39
Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J Biol Chem (1984) 1.39
[Treatment of fallopian tube pregnancies with prostaglandins]. Geburtshilfe Frauenheilkd (1991) 1.38
Supplementary motor seizures mimicking pseudoseizures: some clinical differences. Neurology (1990) 1.38
X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor. Proc Natl Acad Sci U S A (1990) 1.34
Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens. J Immunol Methods (1996) 1.33
Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice. J Gen Virol (1998) 1.32
Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant (1990) 1.30
Acoustic (loudspeaker) facial electromyographic monitoring: Part 1. Evoked electromyographic activity during acoustic neuroma resection. Neurosurgery (1986) 1.29
Relationship between myosin isoenzyme composition, hemodynamics, and myocardial structure in various forms of human cardiac hypertrophy. Circ Res (1985) 1.28
[Heart tumors: incidence, distribution, diagnosis. Exemplified by 20,305 echocardiographies]. Schweiz Med Wochenschr (1991) 1.28
Acute respiratory disease in turkey poults caused by Bordetella bronchiseptica-like bacteria. Vet Rec (1978) 1.27
Rapid determination of nucleotides that define tRNA(Gly) acceptor identity. Proc Natl Acad Sci U S A (1991) 1.27
Growth failure with normal serum RIA-GH and low somatomedin activity: somatomedin restoration and growth acceleration after exogenous GH. J Clin Endocrinol Metab (1978) 1.27
Prediction of cognitive change as a function of preoperative ability status among temporal lobectomy patients seen at 6-month follow-up. Neurology (1991) 1.26
CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo. J Pharmacol Exp Ther (1987) 1.24
Serine proteases mediate apoptosis-like cell death and phagocytosis under caspase-inhibiting conditions. Cell Death Differ (2003) 1.24
Male stimuli are necessary for female sexual behavior and uterine growth in prairie voles (Microtus ochrogaster). Horm Behav (1987) 1.24
Technique of closed chest coronary artery surgery on the beating heart. Eur J Cardiothorac Surg (2001) 1.24
Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook. Klin Padiatr (2003) 1.23
Biochemical characterization of phosphorylation site mutants of simian virus 40 large T antigen: evidence for interaction between amino- and carboxy-terminal domains. J Virol (1991) 1.23
Life-style and occupational risk factors in cancer of the lower urinary tract. Am J Epidemiol (1986) 1.22
Temporal lobe epilepsy due to hippocampal sclerosis in pediatric candidates for epilepsy surgery. Neurology (2001) 1.21
Seroepidemiology of human immunodeficiency virus in Africa. Br Med J (Clin Res Ed) (1986) 1.20
Activation of the promoters of genes associated with DNA damage, oxidative stress, ER stress and protein malfolding by the bile salt, deoxycholate. Toxicol Lett (1999) 1.19
Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group pilot Study. J Clin Oncol (1995) 1.18
The importance of tRNA backbone-mediated interactions with synthetase for aminoacylation. Proc Natl Acad Sci U S A (1998) 1.18
Synthesis and biological activity of acronycine analogs. J Med Chem (1972) 1.17
Adherence of bacteria to vaginal epithelial cells at various times in the menstrual cycle. Infect Immun (1981) 1.17
Direct printing of nanostructures by electrostatic autofocussing of ink nanodroplets. Nat Commun (2012) 1.17
Prevention of Rh sensitization from fetomaternal microtransfusions. Obstet Gynecol (1966) 1.16
Theoretical and perceived balance of power inside Spanish public hospitals. BMC Health Serv Res (2001) 1.15
Mutations of CTNS causing intermediate cystinosis. Mol Genet Metab (1999) 1.15
The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes. Aliment Pharmacol Ther (2010) 1.14
Transient focal abnormalities of neuroimaging studies during focal status epilepticus. Epilepsia (1987) 1.14
Increased estrogen-16 alpha-hydroxylase activity in women with breast and endometrial cancer. J Steroid Biochem (1984) 1.14
The reliability of in vivo structure-function analysis of tRNA aminoacylation. J Mol Biol (1999) 1.13
Clocking femtosecond X rays. Phys Rev Lett (2005) 1.13
Supplementary motor seizures: clinical and electroencephalographic findings. Neurology (1988) 1.13
Intractable epilepsy and structural lesions of the brain: mapping, resection strategies, and seizure outcome. Epilepsia (1991) 1.13
Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human use. Eur J Immunol (1998) 1.13